University California, Davis (117) — Davis, California

University California, Davis (117) is a clinical research site located in Davis, California, United States 95817.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University California, Davis (117) has participated in 1 clinical trials.

Therapeutic areas: AML With Monocytic Differentiation, CMML.

Sponsors: Immune-Onc Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University California, Davis (117)?

University California, Davis (117) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University California, Davis (117) conducted?

University California, Davis (117) has 1 clinical trials on record. Their work covers AML With Monocytic Differentiation, CMML.

Is University California, Davis (117) accredited by Crixeo Health?

University California, Davis (117) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University California, Davis (117)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.